1 Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med. 2002;69(Suppl 2):SII79–82.
2 Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–23.
3 Hoffmann GS, Cid MC, Hellmann DB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309–18.
4 Seitz M, Reichenbach S, Bonel HM, et al. Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 2011;141:w13156.
5 Peter M Villiger, Sabine Adler, Stefan Kuchen, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis:
a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. March 4, 2016. .